» Articles » PMID: 15566303

Time-related Differences in the Physical Property Profiles of Oral Drugs

Overview
Journal J Med Chem
Specialty Chemistry
Date 2004 Nov 30
PMID 15566303
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Comparisons of the calculated physicochemical properties of oral drugs launched prior to 1983 (864 drugs) and between 1983 and 2002 (329 drugs) show that mean values of lipophilicity, percent polar surface area and H-bond donor count are the same, suggesting that these are the most important oral druglike physical properties. In contrast, mean values of molecular weight and the numbers of O + N atoms, H-bond acceptors, and rotatable bonds and rings have increased in 1983-2002 drugs (by 13-29%). Analysis of the 1983-2002 oral drugs by therapy area shows that antiinfectives and nervous system drugs have the most extreme physical property profiles. Cardiovascular drugs show increasing molecular weight with year of publication, primarily a consequence of focusing on clinically proven mechanisms, with limited chemical diversity. Drug classes other than antiinfectives show comparable distributions of lipophilicity, suggesting that this property in oral drugs is important irrespective of the drug's target. The results suggest that the balance between polar and nonpolar drug properties is an important, unchanging feature of oral drug molecules.

Citing Articles

Study of Glabranin as an Inhibitor Against Prostate Cancer: Molecular Docking, Molecular Dynamics Simulation, MM-PBSA Calculation and QSAR Prediction.

Browne R, Goswami N, Borah P, Roy J Indian J Clin Biochem. 2024; 39(3):331-343.

PMID: 39641116 PMC: 11615236. DOI: 10.1007/s12291-023-01134-3.


Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors.

Davison J, Hadjithomas M, Romeril S, Choi Y, Bentley K, Biggins J J Med Chem. 2024; 67(15):13147-13173.

PMID: 39078366 PMC: 11320645. DOI: 10.1021/acs.jmedchem.4c01095.


Benzoxazole-derivatives enhance progranulin expression and reverse the aberrant lysosomal proteome caused by GRN haploinsufficiency.

Tesla R, Guhl C, Werthmann G, Dixon D, Cenik B, Addepalli Y Nat Commun. 2024; 15(1):6125.

PMID: 39033178 PMC: 11271458. DOI: 10.1038/s41467-024-50076-8.


Occurrence of "Natural Selection" in Successful Small Molecule Drug Discovery.

Heinzke A, Pahl A, Zdrazil B, Leach A, Waldmann H, Young R J Med Chem. 2024; 67(13):11226-11241.

PMID: 38949112 PMC: 11247505. DOI: 10.1021/acs.jmedchem.4c00811.


Evaluation of Solubility, Dissolution Rate, and Oral Bioavailability of β-Cyclodextrin and Hydroxypropyl β-Cyclodextrin as Inclusion Complexes of the Tyrosine Kinase Inhibitor, Alectinib.

Majeed B, Saadallah M, Al-Ani I, El-Tanani M, Al Azzam K, Abdallah H Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931404 PMC: 11207005. DOI: 10.3390/ph17060737.